Log in to save to my catalogue

Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing te...

Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing te...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3e541a9800144058a28c32a39366caaa

Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing technology

About this item

Full title

Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing technology

Publisher

England: BioMed Central Ltd

Journal title

BMC genomics, 2024-09, Vol.25 (1), p.898-13, Article 898

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Lung cancer is a heterogeneous disease and the primary cause of cancer-related mortality worldwide. Somatic mutations, including large structural variants, are important biomarkers in lung cancer for selecting targeted therapy. Genomic studies in lung cancer have been conducted using short-read sequencing. Emerging long-read sequencing technologies...

Alternative Titles

Full title

Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing technology

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3e541a9800144058a28c32a39366caaa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3e541a9800144058a28c32a39366caaa

Other Identifiers

ISSN

1471-2164

E-ISSN

1471-2164

DOI

10.1186/s12864-024-10792-3

How to access this item